Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4345846
[patent_doc_number] => 06284726
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5'
[patent_app_type] => 1
[patent_app_number] => 9/612126
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 7841
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284726.pdf
[firstpage_image] =>[orig_patent_app_number] => 612126
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/612126 | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 | Jul 6, 2000 | Issued |
Array
(
[id] => 4368931
[patent_doc_number] => 06274625
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Anti-microbial compound'
[patent_app_type] => 1
[patent_app_number] => 9/509805
[patent_app_country] => US
[patent_app_date] => 2000-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 3737
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274625.pdf
[firstpage_image] =>[orig_patent_app_number] => 509805
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509805 | Anti-microbial compound | Jun 14, 2000 | Issued |
09/403663 | USE OF CONANTOKINS FOR PRODUCING ANALGESIA OR FOR NEUROPROTECTION | May 18, 2000 | Abandoned |
Array
(
[id] => 4274416
[patent_doc_number] => 06281013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Treatment of Infertility'
[patent_app_type] => 1
[patent_app_number] => 9/528917
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4354
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281013.pdf
[firstpage_image] =>[orig_patent_app_number] => 528917
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/528917 | Treatment of Infertility | Mar 19, 2000 | Issued |
09/521164 | New member of the lectin superfamily | Mar 7, 2000 | Abandoned |
Array
(
[id] => 4370298
[patent_doc_number] => 06288028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy'
[patent_app_type] => 1
[patent_app_number] => 9/424414
[patent_app_country] => US
[patent_app_date] => 2000-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 17454
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288028.pdf
[firstpage_image] =>[orig_patent_app_number] => 424414
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/424414 | BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy | Feb 14, 2000 | Issued |
Array
(
[id] => 4290133
[patent_doc_number] => 06268473
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => '.alpha.-conotoxin peptides'
[patent_app_type] => 1
[patent_app_number] => 9/488799
[patent_app_country] => US
[patent_app_date] => 2000-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 16794
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268473.pdf
[firstpage_image] =>[orig_patent_app_number] => 488799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/488799 | .alpha.-conotoxin peptides | Jan 20, 2000 | Issued |
Array
(
[id] => 4187553
[patent_doc_number] => 06160097
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Process for reactivating purified membrane proteins by freezing them'
[patent_app_type] => 1
[patent_app_number] => 9/481699
[patent_app_country] => US
[patent_app_date] => 2000-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1702
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160097.pdf
[firstpage_image] =>[orig_patent_app_number] => 481699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481699 | Process for reactivating purified membrane proteins by freezing them | Jan 11, 2000 | Issued |
Array
(
[id] => 4288827
[patent_doc_number] => 06268390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Therapeutic inhibitor of vascular smooth muscle cells'
[patent_app_type] => 1
[patent_app_number] => 9/470662
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 29
[patent_no_of_words] => 40620
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268390.pdf
[firstpage_image] =>[orig_patent_app_number] => 470662
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/470662 | Therapeutic inhibitor of vascular smooth muscle cells | Dec 21, 1999 | Issued |
Array
(
[id] => 4352310
[patent_doc_number] => 06291428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Peptides which promote bone-forming cell attraction and adhesion'
[patent_app_type] => 1
[patent_app_number] => 9/467423
[patent_app_country] => US
[patent_app_date] => 1999-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 19555
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291428.pdf
[firstpage_image] =>[orig_patent_app_number] => 467423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/467423 | Peptides which promote bone-forming cell attraction and adhesion | Dec 19, 1999 | Issued |
Array
(
[id] => 4262074
[patent_doc_number] => 06204360
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Retro-inverso thymosin alpha 1 hybrids'
[patent_app_type] => 1
[patent_app_number] => 9/465025
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6185
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204360.pdf
[firstpage_image] =>[orig_patent_app_number] => 465025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465025 | Retro-inverso thymosin alpha 1 hybrids | Dec 15, 1999 | Issued |
Array
(
[id] => 4385329
[patent_doc_number] => 06277974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death'
[patent_app_type] => 1
[patent_app_number] => 9/461697
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 262
[patent_no_of_words] => 75976
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277974.pdf
[firstpage_image] =>[orig_patent_app_number] => 461697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/461697 | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | Dec 13, 1999 | Issued |
09/457838 | Secreted protein ZCMP2 | Dec 8, 1999 | Abandoned |
09/439878 | NOVEL METHODS OF DIAGNOSING BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR BREAST CANCER MODULATORS | Nov 11, 1999 | Abandoned |
09/426724 | MEDICAMENTS | Oct 25, 1999 | Abandoned |
Array
(
[id] => 4410118
[patent_doc_number] => 06228836
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Permucous preparation'
[patent_app_type] => 1
[patent_app_number] => 9/402886
[patent_app_country] => US
[patent_app_date] => 1999-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5629
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228836.pdf
[firstpage_image] =>[orig_patent_app_number] => 402886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402886 | Permucous preparation | Oct 17, 1999 | Issued |
Array
(
[id] => 4297909
[patent_doc_number] => 06184351
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => '.alpha.-synuclein super-mutants accelerate .alpha.-synuclein aggregation'
[patent_app_type] => 1
[patent_app_number] => 9/405035
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5183
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184351.pdf
[firstpage_image] =>[orig_patent_app_number] => 405035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/405035 | .alpha.-synuclein super-mutants accelerate .alpha.-synuclein aggregation | Sep 23, 1999 | Issued |
Array
(
[id] => 4411300
[patent_doc_number] => 06310176
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Antimicrobially active polypeptides'
[patent_app_type] => 1
[patent_app_number] => 9/319730
[patent_app_country] => US
[patent_app_date] => 1999-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6592
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310176.pdf
[firstpage_image] =>[orig_patent_app_number] => 319730
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/319730 | Antimicrobially active polypeptides | Aug 23, 1999 | Issued |
Array
(
[id] => 4317891
[patent_doc_number] => 06248579
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins'
[patent_app_type] => 1
[patent_app_number] => 9/372934
[patent_app_country] => US
[patent_app_date] => 1999-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 31401
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248579.pdf
[firstpage_image] =>[orig_patent_app_number] => 372934
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/372934 | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins | Aug 11, 1999 | Issued |
Array
(
[id] => 4286145
[patent_doc_number] => 06268216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Reagents and methods for the screening of compounds useful in the treatment of neurological diseases'
[patent_app_type] => 1
[patent_app_number] => 9/360779
[patent_app_country] => US
[patent_app_date] => 1999-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 19484
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268216.pdf
[firstpage_image] =>[orig_patent_app_number] => 360779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/360779 | Reagents and methods for the screening of compounds useful in the treatment of neurological diseases | Jul 25, 1999 | Issued |